How much is Inmed (Germany) worth in 2026?

Inmed (Germany) has a current valuation of N/A based on their Buyout/LBO (Add-on)† round and secondary market data.

How much funding has Inmed (Germany) raised?

Inmed (Germany) has raised N/A in total funding across 1 funding rounds.

Inmed (Germany)

Enterprise Systems (Healthcare)

Inmed (Germany) valuation and funding history | Last updated: October 22, 2024 | 1 funding rounds

Current Valuation

N/A

As of October 22, 2024

Total Funding Raised

N/A

Across 1 round

Last Round

Buyout/LBO (Add-on)†

Amount undisclosed

Last Funding

Oct 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
October 22, 2024	Buyout/LBO (Add-on)†	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Inmed (Germany) is currently valued at N/A as of October 22, 2024.

Track Inmed (Germany) Valuation Updates

Get notified when Inmed (Germany) raises new funding or valuation changes

Explore More Data

Detailed analysis for Inmed (Germany)

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Inmed (Germany)'s valuation history, funding rounds, and growth metrics.

No credit card required

What is Inmed (Germany) Worth in 2026?

Inmed (Germany) is a leading private company in the Enterprise Systems (Healthcare) sector. Track Inmed (Germany)'s valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Inmed (Germany) Valuation is Determined

Private company valuations like Inmed (Germany)'s are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.